Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines

Virology

Volumn 218, Issue 1, 1996, Pages 224-231

  Fenouillet, Emmanuel ^a,c   Miquelis, Raymond ^a   Drillien, Robert ^b  

^a CNRS   (France)

^b INSERM   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

ARTICLE; CELL LINE; ENZYME LINKED IMMUNOSORBENT ASSAY; GLYCOSYLATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MEMBRANE FUSION; PHENOTYPE; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS RECOMBINANT;

EID: 0029925311     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0182     Document Type: Article

References (27)

1. Dash, B., McIntosh, A., Barrett, W., and Daniels, R. (1994). Deletion of a single N-linked glycosylation site from the transmembrane envelope protein of HIV-1 stops cleavage and transport of gp160 preventing env mediated fusion. J. Gen. Virol. 75, 1389-1397.
2. Dedera, D., VanderHeyden, N., and Ratner, L. (1990). Attenuation of HIV-1 infectivity by an inhibitor of oligossaccharide processing. AIDS Res. Hum. Retroviruses 6, 785-794.
3. Elbein, A. D. (1987). Inhibitors of the biosynthesis and processing of N-linked oligosaccharide chains. Annu. Rev. Biochem. 56, 497-534.
4. Fenouillet, E., and Gluckman, J. C. (1991). Effect of a glucosidase inhibitor on the bioactivity and immunoreactivity of human immunodeficiency virus type 1 envelope glycoprotein. J. Gen. Virol. 72, 1919-1926.
5. Fenouillet, E., Gluckman, J. C., and Jones, I. M. (1994). Functions of HIV envelope glycans. Trends Biochem. Sci. 19, 65-70.
6. Fenouillet, E., and Jones, I. M. (1995). The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160. J. Gen. Virol. 76, 1509-1515.
7. Fenouillet, E., Clerget, B., Gluckman, J. C., Montagnier, L., and Bahraoui, E. (1989). Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor. J. Exp. Med. 169, 807-822.
8. Fenouillet, E., Gluckman, J. C., and Bahraoui, E. (1990). Role of N-linked glycans of envelope glycoproteins in infectivity of human immunodeficiency virus type 1. J. Virol. 64, 2841-2848.
9. Fenouillet, E., Jones, I., Powell, B., Kiény, M. P., and Gluckman, J. C. (1993). Functional role of the glycan cluster of HIV-1 transmembrane glycoprotein gp41. J. Virol. 67, 150-160.
10. Fisher, P. B., Collin, M., Karlsson, G. B., James, W., Butters, T. D., Davis, S. J., Gordon, S., Dwek, R. A., and Platt, F. M. (1995). The α-glucosidase inhibitor N-butyldeoxynojirimycin inhibits HIV entry at the level of post-CD4 binding. J. Virol. 69(9), 5791-5797.
11. Fujimoto, K., and Kornfeld, R. (1991). α-Glucosidase II-deficient cells use Endo-mannosidase as a bypass route for N-linked oligossacharide processing. J. Biol. Chem. 266, 3571-3578.
12. Geyer, H., Holschbach, C., Hunsmann, G., and Schneider, J. (1988). Carbohydrates of human immunodeficiency virus. J. Biol. Chem. 263, 11760-11767.
13. Gruters, R. A., Neefjes, J. J., Tersmette, M., De Goede, R. E. V., Huisman, G., Miedema, R., and Ploegh, H. L. (1987). Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase. Nature (London) 330, 74-77.
14. Helenius, A. (1994). How N-linked oligossaccharides affect glycoprotein folding in the endoplasmic reticulum. Mol. Biol. Cell 5, 253-265.
15. Jones, I., and Jacob, G. S. (1991). Anti-HIV drug mechanism. Nature (London) 352, 198.
16. Kieny, M. P., Lathe, R., Rivière, Y., Dott, K., Schmitt, D., Girard, M., Montagnier, L., and Lecocq, J. P. (1988). Improved antigenicity of the HIV env protein by cleavage site removal. Protein Eng. 2, 219-225.
17. Leonard, C. K., Spellman, M. W., Riddle, L., Harris, R. J., Thomas, J. N., and Gregory, T. J. (1990). Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant HIV envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J. Biol. Chem. 265, 10373-10382.
18. Mizuochi, T., Spellman, M., Larkin, M., Solomon, J., Basa, L., and Feizi, T. (1988). Carbohydrate structures of the human immunodeficiency virus recombinant envelope glycoprotein gp120 produced in Chinese hamster ovary cells. Biochem. J. 254, 599-603.
19. Montefiori, D. C., Robinson, W. E., and Mitchell, W. M. (1988). Role of N-glycosylation in pathogenesis of HIV-1. Proc. Natl. Acad. Sci. USA 85, 9248-9252.
20. Moore, J. P., Jameson, B. A., Weiss, R. A., and Sattentau, Q. (1993). In "Viral Fusion Mechanisms" (J. Bentz, Ed.), pp. 230-289. CRC Press, Boca Raton, FL.
21. Pal, R., Kalyanaraman, V. S., Hoke, G., and Sarnghadaran, M. G. (1989a). Processing and secretion of envelope glycoproteins of HIV-1 in the presence of trimming glucosidase inhibitor deoxynojirimycin. Intervirology 30, 27-35.
22. Pal, R., Hoke, G., and Sarnghadaran, M. G. (1989b). Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86, 3384-3388.
23. Ratner, L. (1992). Glucosidase inhibitors for treatment of HIV-1 infection. AIDS Res. Hum. Retroviruses 8, 165-173.
24. Ratner, L., Vander Heyden, N., and Dedera, D. (1991). Inhibition of HIV and SIV infectivity by blockade of α-glucosidase activity. Virology 181, 180-192.
25. Spehner, D., Gillard, S., Drillien, R., and Kim, A. (1988). A cowpox virus gene required for multiplication in Chinese hamster ovary cells. J. Virol. 62, 1297-1304.
26. Stanley, P. (1993). Use of mammalian cell mutants to study the functions of N- and O-linked glycosylation. In "Cell Surface and Extracellular Glycoconjugates." Academic Press, San Diego.
27. Tarentino, A. L., Trimble, R. B., and Plummer, T. H. (1989). Enzymatic approaches for studying the structure, synthesis, and processing of glycoproteins. Methods Cell Biol. 32, 111-139.